| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 14/07/16 | | 13:02:12 | 14 Jul 2016 | | | Price Monitoring Extension | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:56:49 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:54:30 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:51:58 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:49:47 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:47:23 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:44:48 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:44:24 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:41:45 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:37:17 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:34:05 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:32:08 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:19:29 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/07/16 | | 18:10:25 | 12 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/07/16 | | 17:25:48 | 1 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/07/16 | | 12:32:00 | 1 Jul 2016 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 20/06/16 | | 08:02:24 | 20 Jun 2016 | | | FULFIL Study Results Closed Triple EU | GlaxoSmithKline PLC | RNS |
| 14/06/16 | | 11:58:50 | 14 Jun 2016 | | | Directorate Change | GlaxoSmithKline PLC | RNS |
| 10/06/16 | | 18:09:18 | 10 Jun 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/06/16 | | 17:48:56 | 10 Jun 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/06/16 | | 13:00:06 | 8 Jun 2016 | | | Phase III Study of Sirukumab Results | GlaxoSmithKline PLC | RNS |
| 02/06/16 | | 08:00:07 | 2 Jun 2016 | | | Closed Triple Combined FF-UMEC-VI US Filing Plans | GlaxoSmithKline PLC | RNS |
| 01/06/16 | | 10:55:11 | 1 Jun 2016 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 27/05/16 | | 16:46:27 | 27 May 2016 | | | Strimvelis receives EC marketing authorisation | GlaxoSmithKline PLC | RNS |
| 27/05/16 | | 15:56:02 | 27 May 2016 | | | Board and Committee changes | GlaxoSmithKline PLC | RNS |
| 24/05/16 | | 11:54:42 | 24 May 2016 | | | Salford Lung Study Results | GlaxoSmithKline PLC | RNS |
| 23/05/16 | | 16:47:06 | 23 May 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/05/16 | | 11:56:04 | 13 May 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/05/16 | | 17:52:21 | 12 May 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/05/16 | | 12:48:14 | 11 May 2016 | | | Block listing Interim Review | GlaxoSmithKline PLC | RNS |
| 10/05/16 | | 18:15:33 | 10 May 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/05/16 | | 14:05:41 | 9 May 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/05/16 | | 18:41:33 | 5 May 2016 | | | Result of AGM | GlaxoSmithKline PLC | RNS |
| 03/05/16 | | 12:21:18 | 3 May 2016 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 27/04/16 | | 13:00:03 | 27 Apr 2016 | | | 1st Quarter Results | GlaxoSmithKline PLC | RNS |
| 01/04/16 | | 16:33:02 | 1 Apr 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/04/16 | | 16:19:15 | 1 Apr 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/04/16 | | 16:07:46 | 1 Apr 2016 | | | GSK receives positive CHMP opinion for Strimvelis | GlaxoSmithKline PLC | RNS |
| 01/04/16 | | 14:01:11 | 1 Apr 2016 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/03/16 | | 18:48:48 | 30 Mar 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 30/03/16 | | 13:00:04 | 30 Mar 2016 | | | Notice of AGM | GlaxoSmithKline PLC | RNS |
| 29/03/16 | | 18:23:33 | 29 Mar 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 29/03/16 | | 08:01:36 | 29 Mar 2016 | | | Marketing approval received for Nucala® in Japan | GlaxoSmithKline PLC | RNS |
| 22/03/16 | | 15:14:02 | 22 Mar 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 21/03/16 | | 16:09:03 | 21 Mar 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 21/03/16 | | 07:00:07 | 21 Mar 2016 | | | Annual Report 2015 on Form 20-F | GlaxoSmithKline PLC | RNS |
| 18/03/16 | | 14:58:05 | 18 Mar 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
